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Background: Motor cortex excitability was found to be changed after repetitive transcranial magnetic stimulation
(rTMS) of the temporal cortex highlighting the occurrence of cross-modal plasticity in non-invasive brain stimulation.
Here, we investigated the effects of temporal low-frequency rTMS on motor cortex plasticity in a large sample of
tinnitus patients. In 116 patients with chronic tinnitus different parameters of cortical excitability were assessed
before and after ten rTMS treatment sessions. Patients received one of three different protocols all including 1 Hz
rTMS over the left temporal cortex. Treatment response was defined as improvement by at least five points in the
tinnitus questionnaire (TQ). Variables of interest were resting motor threshold (RMT), short-interval intra-cortical
inhibition (SICI), intracortical facilitation (ICF), and cortical silent period (CSP).
Results: After rTMS treatment RMT was decreased by about 1% of stimulator output near-significantly in the whole
group of patients. SICI was associated with significant changes with respect to treatment response. The group of
treatment responders showed a decrease of SICI over the course of treatment, the group of non-responders the
reverse pattern.
Conclusions: Minor RMT changes during rTMS treatment do not necessarily suggest the need for systematic
re-examination of the RMT for safety and efficacy issues. Treatment response to rTMS was shown to be related
to changes in SICI that might reflect modulation of GABAergic mechanisms directly or indirectly related to rTMS
treatment effects.
Keywords: Transcranial magnetic stimulation, Motor cortex excitability, Motor cortex plasticity, Tinnitus, Cross-modal
plasticity, Cortical silent period, Motor threshold, Intracortical inhibition, Intracortical facilitationBackground
Tinnitus is associated with neural changes in both the
auditory pathway and in non-auditory brain areas [1].
Tinnitus related changes of activity and connectivity in
frontal, temporal, parietal, and limbic areas e.g. [2,3] seem
to reflect pathologically altered brain networks [4,5]. Based
on these findings repetitive transcranial magnetic stimula-
tion (rTMS) was introduced as a treatment approach in* Correspondence: martin.schecklmann@medbo.de
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article, unless otherwise stated.tinnitus [6]. However, it turned out that the treatment ef-
fects are moderate and associated with high inter-individual
variability which raises the need for indicators for effective
therapy. Clinical trials of rTMS in tinnitus use typically
stimulation of one or both temporal/auditory or temporo-
parietal cortices. Recently these protocols were extended by
additional stimulation of non-auditory areas such as the
frontal cortex to target tinnitus-specific networks more ef-
fectively [7,8].
Repetitive transcranial magnetic stimulation (rTMS) as
a therapeutic intervention consists of non-invasive re-
peated stimulation of neocortical areas for hundreds ofentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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induction. The TMS coil is placed on the subjects’ head
over the target area and short-lasting high-intense currents
in the coil produce a strong magnetic field (up to 1.5 T),
which passes largely undistorted through the scull and in-
duces neuronal depolarisations in the underlying cortical
area. rTMS leads to long-term depression- or potentiation-
like neuroplastic changes [9]. Low-frequency 1Hz rTMS of
motor cortex induces long-term depression as indicated by
motor cortex excitability parameters [10]. Effects take place
in the directly stimulated cortical area and also in function-
ally connected remote areas, presumably via cortico-
cortical connectivity [11]. For example, stimulation of the
dorso-lateral prefrontal cortex is associated with blood flow
changes in the anterior cingulate cortex [11,12] or dopa-
mine release in the caudate nucleus [13].
In addition TMS can also be used as a diagnostic tool for
the assessment of motor cortex excitability by quantifying
contractions of peripheral muscles induced by stimulation
of the corresponding motor cortex representation. Assess-
ment of motor cortex excitability in a longitudinal study
design before and after a specific therapeutic intervention
(e.g. multiple sessions of rTMS) enables to describe
treatment-related neuroplastic changes. It has been
shown, that rTMS over the temporal cortex can induce
changes in motor cortex excitability. In a sham-controlled
study 27 healthy subjects showed decreased motor evoked
potential amplitudes and delayed cortical silent period
(CSP) after five days of 1Hz rTMS of the right temporal
cortex [14]. Furthermore, these changes were accompanied
by a decrease in glucose metabolism in the stimulated tem-
poral cortex and an increase in cingulate and frontal areas
but also in motor cortex. Five days of active low-frequency
rTMS over auditory cortex lead to prolongation of the CSP
in 18 healthy subjects [15], whereas sham rTMS had not
such effects. Clinical benefit of the same protocol in ten pa-
tients with tinnitus was positively correlated with changes
in short-interval intra-cortical inhibition (SICI), intracortical
facilitation (ICF), and CSP [16].
In conclusion, these studies highlight the existence of
cross-modal plasticity in rTMS studies in tinnitus or
with temporal stimulation. Evidence for functional con-
nectivity between temporal and motor cortex comes
from neurophysiologic and brain metabolism studies
[17,18]. In tinnitus, the interaction between the sensori-
motoric and the auditory system is well established and
clinically reflected by somatosensoric modulation of the
tinnitus percept [19]. Here, we aimed to investigate the
effects of temporal rTMS on different motor cortex ex-
citability parameters in the biggest investigated tinnitus
sample so far by means of a retrospective analysis of
data obtained in the context of different clinical trials.
As only one study in tinnitus with a small sample size
was done so far we especially focused on the associationof clinical response with change in excitability in the
quest for a non-auditory neurophysiological indicator for
effective therapy.
Methods
Subjects
All participants gave written informed consent after a com-
prehensive explanation of the procedures. All studies whose
data contributed to this analysis were approved by the
Ethics Committee at the University of Regensburg. All
experiments were conducted in accordance with the
last revision of the Declaration of Helsinki.
Measurements of cortical excitability were performed
in 116 patients (84 (72.4%) males; 49.2 ± 12.5 (21–83)
years) with chronic tinnitus (duration 90 ± 94 (2–476)
months). 28 (25.2%) out of 111 patients (data of 5 pa-
tients not available) reported a purely left-sided, 21
(18.9%) a purely right-sided tinnitus, and 62 (55.9%) pa-
tients described their tinnitus as bilateral or originating
within the head. Tinnitus distress was assessed by the
German version [20] of the Tinnitus questionnaire (TQ)
[21]; TQ baseline scores ranged from 3 to 79 (41 ± 18).
Patients suffering from Meniere’s disease, presenting con-
ductive hearing loss or displaying hints of objective tinnitus
were not included. 62 patients underwent a complete
otologic and audiologic examination including pure tone
audiometry, tympanometry, stapedius reflex tests, and oto-
scopy. Mean hearing level of the audiogram (bilateral hear-
ing thresholds at 0.125, 0.25, 0.5, 1, 2, 3, 4, 6, 8 kHz) was
17 ± 13 (0–61 dB HL). Only patients were included that
were eligible for rTMS treatment. Thus, patients with car-
diac pacemakers, history of seizures, suspected diagnosis of
organic brain damage or any other severe somatic, neuro-
logic, or psychiatric diagnosis were not included.
Procedures
The therapeutic intervention consisted of 10 rTMS ses-
sions on consecutive weekdays. Treatment effects were
evaluated by changes in TQ between the first (day 1)
and the last day of treatment (day 12). Motor cortex ex-
citability was examined on the first day before treatment
and on the last day after rTMS. We analyzed longitu-
dinal data of 116 patients participating in three different
treatments studies [7,22]. Patients received one out of
three different active stimulation protocols (2000 stimuli
over auditory cortex with 1Hz: n = 68; 4000 stimuli over
auditory cortex with 1Hz: n = 26; 2000 stimuli over left
frontal cortex with 20Hz followed by 2000 stimuli over
auditory cortex with 1Hz: n = 22). Stimulation was set to
110% of the individual resting motor threshold. Localization
of the stimulated areas was either done with a neuronaviga-
tional system or by using a standard procedure based on
the 10–20 system [23]. Recent analyses did not reveal clin-
ically relevant differences in treatment efficacy depending
Schecklmann et al. BMC Neuroscience 2014, 15:71 Page 3 of 7
http://www.biomedcentral.com/1471-2202/15/71on the used method for coil positioning [7]. In detail,
each patient was treated with one protocol lasting ten
days and one kind of localization that means that there
were sub-groups with different treatments. Data were
recorded from 2004 to 2009. All measurements were
performed by the same staff which was experienced in
the used methods.
For measurement of cortical excitability, participants
were seated in a reclining chair. TMS was delivered by
two Magstim 200 stimulators (Magstim Co., UK) con-
nected via a Bistim module to a figure-of-eight coil
(double-circular-70-mm coil). The coil was held tangen-
tial to the skull and with the handle pointing backwards
and about 45° away from the midline. The optimal coil
position for stimulation was defined as the position
above the left motor cortex for eliciting MEP of maximal
amplitude in abductor digiti minimi muscle with a slightly
supra-threshold stimulus. Once this position was found, it
was marked on a scientific head cap and the coil was held
in this position by the investigator.
Motor evoked potentials (MEPs) of the abductor digiti
minimi of the right hand were recorded with surface
electrodes. The analogue signal was registered, band-
pass filtered between 20 Hz and 10 kHz, then digitised
at a frequency of 5 kHz and analysed off-line. Resting
motor threshold (RMT) was determined as the lowest
stimulation intensity that evoked in at least four out of
eight consecutive trials a MEP of at least 50 μV in the
resting abductor digiti minimi [24]. Active motor thresh-
old was defined as the lowest stimulation intensity that
evoked in at least four out of eight consecutive trials a
MEP of at least 250 μV during isometric contraction of
the abductor digiti minimi at about 20% of maximum
voluntary contraction. A constant level of voluntary
contraction was maintained by audiovisual feedback
of the electromyographic (EMG) activity. MEP amplitudes
were measured peak-to-peak.
Short-interval intra-cortical inhibition (SICI) and
intra-cortical facilitation (ICF) were measured with a
paired-pulse TMS protocol [25]. The intensity of the first
(conditioning) stimulus was set at 90% of the active
motor threshold. The second stimulus was delivered at
an intensity that produced MEPs of about 1 mV in the
resting abductor digiti minimi. Interstimulus intervals
(ISIs) were 2 ms and 15 ms to measure short-interval
intra-cortical inhibition (reduction of amplitude) and
intracortical facilitation (increase of amplitude), respect-
ively [25]. The conditioned stimuli and the control con-
dition (test pulse alone) were each tested 10 times in a
random order (inter-sweep-interval: 4 s). The effect of
conditioning stimuli on MEP amplitude at each ISI was
determined as the ratio of the average amplitude of con-
ditioned MEP (cMEP) to the average amplitude of un-
conditioned test MEP (uMEP).Cortical silent period was measured in 10 trials (stimu-
lus intensity: 150% resting motor threshold; inter-sweep-
interval: 5 s) in the moderately active abductor digiti
minimi muscle on the non-rectified recording of every
individual sweep and then averaged [26]. Participants
were instructed to contract this muscle at 30% max-
imum strength. The onset of the cortical silent period
was defined as the end of the MEP when activity
dropped consistently below pre-stimulus EMG level.
The end of the cortical silent period was defined as first
reappearance of voluntary EMG activity. In conclusion,
TMS variables of interest were resting motor threshold
(RMT), cMEP/uMEP ratio of 2 ms and 15 ms interstim-
ulus intervals (SICI and ICF, respectively), and cortical
silent period (CSP).
Statistics
Statistics are based on retrospective analysis. We were
interested if changes of motor cortex excitability were
related to rTMS treatment per se and to rTMS induced
clinical response. Thus, we did an analysis of variance
with treatment as within-subjects factor (first vs. last day
of treatment) and treatment response as between-
subjects factor (responder vs. non-responder). Treat-
ment response was defined as change in TQ of at least 5
points [27,28]. If an ANOVA revealed significant results,
we performed post-hoc t-tests for comparison of re-
sponders and non-responders before and after rTMS
and for the changes in both groups over time. We were
interested in effects of rTMS protocols as potential con-
founder and repeated these ANOVAs with rTMS proto-
col as covariate (2000 stimuli temporal vs. 4000 stimuli
temporal vs. 2000 stimuli frontal and 2000 temporal) for
the significant effects.
As we had four variables of interest (RTM, SICI, ICF,
and CSP), significance threshold was set to a Bonferroni
corrected level (0.05/4 = 0.0125). For post-hoc tests sig-
nificance threshold was set to 5%. Statistical analyses
were performed with SPSS 18.0.0 (SPSS, USA). As the
focus of this analysis were rTMS induced effects on
cortical excitability we abstain from reporting treatment
efficacy data which have already been published else-
where [7,22,29,30].
Results
Firstly, rTMS resulted in a near significant decrease in
RMT (reduction by 1% stimulator output) in the whole
study population (Table 1). Other parameters of motor
cortex excitability remained unchanged. We did not find
significant interaction effects of “rTMS protocol” with
change in RMT, SICI, ICF, and CSP.
We found no significant effects of treatment (pre vs.
post rTMS). For RMT there was a tendency towards a
reduction (of about 1% stimulator output; p = 0.024) but
Table 1 Descriptive and statistical data of changes in motor cortex excitability in dependence from rTMS intervention
and treatment response
pre rTMS post rTMS Main effect
treatment
Main effect
response
Interaction
effect
resting motor threshold non-
responder
42.6 ± 8.2 41.5 ± 8.5 F = 52.679; F = 0.062; F = 0.268;
df = 1,114; df = 1,114; df = 1,114;
responder 42.8 ± 7.8 42.0 ± 8.0 p = 0.024+ p = 0.805 p = 0.606
short-interval intra-cortical
inhibition
non-
responder
0.58 ± 0.51 0.47 ± 0.28 F = 0.319; F = 2.323; F = 6.447;
df = 1,114; df = 1,114; df = 1,114;
responder 0.41 ± 0.29 0.47 ± 0.33 p = 0.574 p = 0.130 p = 0.012*
intra-cortical facilitation non-
responder
1.68 ± 1.24 1.43 ± 0.74 F = 3.079; F = 3.474; F = 2.823;
df = 1,114; df = 1,114; df = 1,114;
responder 1.32 ± 0.39 1.32 ± 0.36 p = 0.082 p = 0.065 p = 0.096
cortical silent period non-
responder
0.108 ±
0.040
0.107 ±
0.044
F = 0.080; F = 1.818; F = 0.179;
df = 1,114; df = 1,114; df = 1,114;
responder 0.118 ±
0.065
0.123 ±
0.104
p = 0.778 p = 0.180 p = 0.673
*significant at a Bonferroni corrected threshold with p-values displayed uncorrected; +near significant at a Bonferroni corrected threshold with p-values
displayed uncorrected.
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cance level. There was no main effect of group (re-
sponder vs. non-responder) either. With respect to the
group x treatment interaction there was a significant
interaction effect between the change in SICI and the
clinical response to rTMS (p = 0.012; Table 1, Figure 1).
As post-hoc t-tests indicate, responders showed a reduc-
tion of SICI (t = 2.327; df = 56; p = 0.024) and non-
responders an increase in SICI (t = 1.737; df = 58; p =
0.088) due to the rTMS intervention. Please note that
reduction in SICI is mirrored by a numerical increase of
the amplitude ratio between the conditioned stimulus
and the test stimulus. Responders significantly differed in
their SICI from non-responders before treatment (t = 2.282;Figure 1 Raw data (mean ± se) of the short-interval intra-
cortical inhibition (SICI) for the significant interaction effect of
the analysis of variance with the factors rTMS treatment and
treatment response.df = 114; p = 0.024) whereas there was no difference at the
end of treatment (t = 0.002; df = 114; p = 0.999). For the
other investigated parameter (RMT, ICF, CSP) the inter-
action group x treatment was not significant. ANOVAs
with rTMS protocol as covariate affirmed the significant
findings for RMT (p = 0.091) and SICI (p = 0.013) indicat-
ing no influence of the rTMS protocol. Detailed statistic
and descriptive data are given in Table 1.Discussion
Treatment of 10 days of rTMS over auditory cortex in
116 patients with chronic tinnitus resulted in a near sig-
nificant, but very small reduction of RMT (1% stimulator
output) for the whole group. Since stimulation intensity
in most rTMS treatment studies is adjusted to the rest-
ing motor threshold (RMT) several earlier studies inves-
tigated whether rTMS treatment changes the RMT
[5,14-16,31-42]. Findings in these studies are not entirely
consistent and it also remains unclear whether observed
fluctuations of RMT during the course of rTMS treat-
ment rather reflect variations of cortical excitability or
rather an inherent inaccuracy of the measurement pro-
cedure of the RMT [43]. Despite these uncertainties
there are recommendations to re-measure the RMT over
the course of treatment and to adjust the stimulation in-
tensity accordingly [5]. However, the mean reduction by
about 1% of the stimulator output in our sample rather
suggests that the induced changes in RMT are negligible.
Changes in cortical excitability would be meaningful if
RMT were shown to be reliable and if stimulation inten-
sity was falling above safe intensity or below effective
targeting the brain due to changes of RMT.
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tion in the TQ showed increased SICI at the beginning
of the treatment and a reduction over the course of the
treatment. Non-responders showed the reverse pattern.
Because of the lack of a placebo group we cannot defini-
tively conclude that the observed reduction of SICI
during treatment in the responder-group is related to suc-
cessful rTMS treatment. Theoretically the SICI change
could also reflect tinnitus reduction alone, independently
of the kind of intervention. However the fact that the
responder and non-responder group also differed in their
baseline values of SICI makes the latter explanation ex-
tremely unlikely.
A relationship between treatment response and a re-
duction of SICI has not yet been reported before. The
discrepancy to previous results may be related to statis-
tical power since the here presented data are from the
biggest sample so far. Two studies in healthy controls
found no effects of temporal rTMS on SICI [14,15]; in a
small sample of tinnitus patients low frequency temporal
rTMS increased SICI [16] and also high frequency pre-
frontal rTMS in patients with major depression in-
creased SICI [31]. However, authors stimulated the left
dorso-lateral prefrontal cortex with 20Hz. We used three
different treatments all including temporal 1Hz stimula-
tion of the auditory cortex with one treatment including
a 20Hz stimulation of left dorso-lateral prefrontal cortex
before the temporal stimulation. We did not find any
treatment specific effects. One could speculate that op-
posite effects on SICI after low frequency (decrease of
SICI in the present study) and high-frequency rTMS [in-
crease of SICI in 31] may reflect the well-established
frequency-dependency of the direction of rTMS treatment
effects [10]. However, it is unclear, whether the findings
from motor cortex can be directly transferred to non-
motor areas since the exact mechanism of the observed
cross-modal interaction still remains to be elucidated.
Nevertheless, our findings of altered SICI add further
evidence to the notion of cross-modal plasticity of motor
cortex in context of stimulation of non-motor areas.
Considered mechanisms as indicated by studies in syn-
aesthesia and sensory deprivation (e.g. deafness or blind-
ness) may take place via multi-sensory association areas,
via direct cortico-cortical connections, or via subcortical
interplay of the corresponding sensory systems at the
thalamic level [44-47]. In tinnitus and other neuro-
psychiatric disorders, the model of thalamocortical dys-
rhythmia considers altered thalamic activity due to
deprived afferent input as the core of the pathology. This
altered thalamic activity is generating altered cortical ac-
tivity which in turn induces symptoms such as phantom
perceptions [48]. Based on this concept one could as-
sume that the observed effects on motor cortex excit-
ability in treatment responders are mediated via rTMSinduced modulation of thalamic activity. The exact mech-
anism which underlies the observed cross-modal plasticity
effect in this study might be best evaluated by future con-
nectivity studies. Dynamic causal modelling would enable
the modelling of the direction of information flow of as-
sumed network hubs. Such studies could elucidate, whether
our findings may reflect region-specific changes mediated
via specific cross-modal pathways or rather global changes
as an unspecific response to local stimulation.
Beside anatomical considerations of cross-modal plas-
ticity, our findings can also be discussed in the context
of trans-synaptic chemical signalling. Both antidepressant
effects [31] and tinnitus reduction [49], are mediated by
the inhibitory-acting γ-aminobutyric acid (GABA). GABA
is also involved in motor cortex excitability and plasticity
for an overview [50,51]. Especially SICI is mediated by
GABAergic interneurons within the primary motor cortex
[50,52]. For tinnitus, evidence for GABAergic involvement
comes from pharmacological treatments [for an overview
49], animal models [53], and genetic analyses e.g., [54].
Recent studies in animal models of tinnitus identified defi-
cient inhibitory function in input-deprived auditory re-
gions [53]. If low frequency rTMS reduces tinnitus by
renormalizing inhibitory function in the auditory cortex,
the observed reduction of SICI in treatment responders
could reflect the subsequent reduction of a compensatory
global inhibitory effort. Following this reasoning the in-
creased baseline SICI may then reflect reduced inhibitory
tone in the auditory system. It seems reasonable that
rTMS can only exert an effect on tinnitus, if the inhibitory
function in the auditory system is altered. In this study we
found no effects for other excitability measures. Since
RMT, ICF and CSP are rather modulated by other neuro-
transmitters and -receptors, our findings highlight the role
of GABAA mediated neurotansmission in rTMS treat-
ment effects in tinnitus [41,42]. We are well aware that
this interpretation is highly speculative and needs to be
confirmed by further studies, before further conclusions
can be drawn.
On a functional level auditory-motor connectivity
might be related to functions of speech or music percep-
tion. The motor theory of speech perception links vocal
tract gestures to the perception of speech [55]. Beat in-
duction and rhythm perception helps to identify regular
patterns in music with the aim to get synchronised by
clapping, dancing, or singing [56]. Electrophysiological
markers of this transfer may be grounded in the exist-
ence of rhythmic oscillatory activity of mu or alpha-like
frequencies [57]. Based on these considerations the ana-
tomical, neurotransmitter, and functional association of
treatment response to temporal stimulation in tinnitus
with SICI highlights the role of auditory-motor connect-
ivity in rTMS treatment of tinnitus. Future clinical ap-
proaches might be the identification of responders of
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after single rTMS sessions.
Conclusions
The counterpoint to the big sample size are the missing
control groups and the retrospective analysis. Therefore
further prospective studies including control groups are
needed before firm conclusions about the specifity of the
observed effects for rTMS treatment of tinnitus can be
drawn. Moreover consecutive, daily measurements would
enable to better characterise the time course of changes in
excitability.
Nevertheless the presented data add to the literature
that rTMS of non-motor areas can induce changes in
motor cortex excitability. RMT changes during rTMS
treatment seem to be negligible and do not affirm the
potential need for re-evaluation of the stimulation inten-
sity during treatment for efficacy and safety issues. SICI
changes might reflect modulation of GABAergic mecha-
nisms directly or indirectly related to rTMS treatment
effects.
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